Sierra, you should speak to people who know how mi

Sierra, you should speak to people who know how microtiter plates (like the N-Assay) are used. The only difference from bacteria to virus would be in the antibody used as the primary antibody coating in the wells of the plate. Whatever the process is that Nanologix uses to make the Group B Strep and other tests rapid would apply to the virus antibody also. So the configuration for Ebola and looking for a corporate partner to do this probably has more to do with the biohazard level (BSL-4) of the virus than complexity of the configuration. With the right partner it should be a few weeks to do it all. Without a partner, it won't happen. To get the N-Assay out there to help fight Ebola would be the reason for the press release. The statements from both Mr. Barnhizer and Dr. Faro are very clear.